Jay Reilly

With his private practice and in-house experience, Jay Reilly brings to clients a dual perspective of legal issues facing businesses. He has a deep knowledge of the bio-tech, life sciences and pharmaceutical industries and regularly counsels entrepreneurs and early-stage companies on a wide variety of business matters.

Prior to joining Saul Ewing Arnstein & Lehr, Jay was General Counsel and Chief Compliance Officer for Emergent BioSolutions, a publicly traded specialty pharmaceutical company in Washington, D.C. In this position, Jay managed the company's in-house legal staff and monitored government contract and compliance matters. He has extensive knowledge of securities law compliance and has directed numerous complex corporate transactions, including mergers and acquisitions, real estate deals, joint ventures, strategic alliances and licensing agreements. In addition, Jay has first-hand experience counseling members of boards of directors on governance, fiduciary duties and risk mitigation.